Related Experiment Videos
[Experience in treating a herpetic infection with trypsin]
Abstract:
Results are reported of trypsin treatment of 150 patients with herpetic infection (age of the patients: from 7 to 65 years). The results were compared with routine treatment in 200 patients. High efficacy of trypsin treatment as compared with routine treatment methods has been revealed. Trypsin treatment results in control of the pathological signs and symptoms not only in the acute period but also resulted in absence of recurrences of the infection and postherpetic neuralgia for 3 successive years. The efficacy of trypsin treatment has been thus established and the necessity of active detection and treatment of chronic carriers of herpetic infection by the proposed method is advocated.
Insights
Trypsin treatment significantly outperforms routine methods for herpetic infections. This approach controls acute symptoms and prevents recurrences and postherpetic neuralgia for up to three years.
Area of Science:
- Virology
- Dermatology
- Pharmacology
Background:
- Herpetic infections pose a significant clinical challenge, often leading to persistent symptoms and complications.
- Current routine treatments for herpetic infections have limitations in managing acute phases and preventing long-term sequelae.
- Chronic carriers of herpetic infections represent a reservoir for disease transmission and require effective therapeutic strategies.
Observation:
- A study evaluated the efficacy of trypsin treatment in 150 patients diagnosed with herpetic infections, ranging in age from 7 to 65 years.
- Treatment outcomes were compared against a control group of 200 patients receiving standard care.
- Clinical observations focused on the resolution of acute symptoms and the long-term prevention of infection recurrence and postherpetic neuralgia.
Findings:
- Trypsin treatment demonstrated superior efficacy compared to routine treatment methods for herpetic infections.
- Patients receiving trypsin experienced effective control of pathological signs and symptoms during the acute phase of infection.
- Notably, trypsin treatment led to an absence of infection recurrences and postherpetic neuralgia for three consecutive years post-treatment.
Implications:
- The findings establish trypsin as a highly effective therapeutic agent for managing herpetic infections.
- Active detection and treatment of chronic herpetic infection carriers using trypsin are strongly advocated.
- This approach holds potential for reducing the burden of herpetic infections and associated complications, including chronic pain.